Low grade chronic inflammation in women with polycystic ovarian syndrome

Cited by (639)

Items 301–400 of 639

1. Elevated coagulation and inflammatory markers in adolescents with a history of premature adrenarche
   Sarantis Livadas, Maria Dracopoulou, Karmen Vasileiadi, Christina Lazaropoulou, Maria Alexandra Magiakou, Paraskevi Xekouki, Antonis Voutetakis, Christina Kanaka‐Gantenbein, Ioannis Papassotiriou, Christodoulos Stefanadis et al. · 2009 · Metabolism
2. The peripheral blood transcriptome identifies dysregulation of inflammatory response genes in polycystic ovary syndrome
   Nianjun Su, Jian Ma, De-feng Feng, Shuai Zhou, Zi-Tao Li, Weiping Zhou, Hua Deng, Jiaying Liang, Xuhui Yang, Yuemei Zhang et al. · 2017 · Gynecological Endocrinology
3. The Possible Practical Implication of High CRP Levels in PCOS
   Zeev Blumenfeld · 2019 · Clinical Medicine Insights Reproductive Health
4. C-Reactive protein in relation to fecundability and anovulation among eumenorrheic women
   Rose G. Radin, Lindsey A. Sjaarda, Robert M. Silver, Carrie J. Nobles, Sunni L. Mumford, Neil J. Perkins, Brian D. Wilcox, Anna Z. Pollack, Karen Cecilia Schliep, Torie Comeaux Plowden et al. · 2018 · Fertility and Sterility
5. Detection of Polycystic Ovarian Syndrome: A Literature Survey
   A. Saravanan, S. Sathiamoorthy · 2018 · Asian Journal of Engineering and Applied Technology
6. The Kynurenine Pathway and Polycystic Ovary Syndrome: Inflammation as a Common Denominator
   Filip Jovanovic, A. Sudhakar, N. Knezevic · 2022 · International Journal of Tryptophan Research
7. Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome
   Mei‐Jou Chen, Wei‐Shiung Yang, Hsin‐Fu Chen, J.-J. Kuo, Hong‐Nerng Ho, Yu‐Shih Yang, Shee‐Uan Chen · 2010 · Human Reproduction
8. Metabolic Features of Women With Polycystic Ovary Syndrome in Latin America: A Systematic Review
   Lucas Bandeira Marchesan, Ramon Bossardi Ramos, Poli Mara Spritzer · 2021 · Frontiers in Endocrinology
9. C-reactive protein and homocysteine levels are associated with abnormal heart rate recovery in women with polycystic ovary syndrome
   Cemil Kaya, Ebru Akgül, Recai Pabuçcu · 2009 · Fertility and Sterility
10. Inflammation and its Association with Glucose Disorders and Cardiovascular Disease
    Joshua I. Barzilay, Eric S. Freedland · 2003 · Treatments in Endocrinology
11. Hyperreninemia Characterizing Women with Polycystic Ovary Syndrome Improves after Metformin Therapy
    Evanthia Diamanti‐Kandarakis, Frangiskos Economou, Sarantis Livadas, Evangelia Tantalaki, Christina Piperi, Athanasios G. Papavassiliou, Dimitrios Panidis · 2009 · Kidney & Blood Pressure Research
12. Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?
    Yaprak Engin Üstün, Yusuf Üstün, M. Mutlu Meydanli, Ayşe Kafkaslı, Gülay Yetkin · 2006 · Gynecological Endocrinology
13. Elevated ovarian pentraxin 3 in polycystic ovary syndrome
    Jiexue Pan, Chengliang Zhou, Zhiyang Zhou, Zuwei Yang, Tiantian Dai, Hefeng Huang, Jin Li · 2021 · Journal of Assisted Reproduction and Genetics
14. Effects of jnk inhibitor on inflammation and fibrosis in the ovary tissue of a rat model of polycystic ovary syndrome.
    Gülay Bulut, Zehra Kurdoğlu, Yeliz Bozdemır Donmez, Mertihan Kurdoğlu, Remzi Erten · 2015 · PubMed Central
15. Expression of the CD11c gene in subcutaneous adipose tissue is associated with cytokine level and insulin resistance in women with polycystic ovary syndrome
    Tao Tao, Shengxian Li, Aimin Zhao, Yanyun Zhang, Wei Yong Liu · 2012 · European Journal of Endocrinology
16. Effects of Flax Seeds Supplementation in PolyCystic Ovarian Syndrome
    Fatima Farzana K, Abubacker Sulaiman F, A. Ruckmani, K.S. Vijayalakshmi, Karunya Lakshmi G, Shri Ranjini S, Murugan Duraivel · 2015
17. Testosterone and immune-reproductive tradeoffs in healthy women
    Tierney K. Lorenz, Julia R. Heiman, Gregory E. Demas · 2016 · Hormones and Behavior
18. Enhanced Inflammation without Impairment of Insulin Signaling in the Visceral Adipose Tissue of 5α-Dihydrotestosterone-Induced Animal Model of Polycystic Ovary Syndrome
    Danijela Vojnović Milutinović, Marina Nikolič, Nataša A. Veličković, Ana D. Djordjevic, Biljana N. Bursać, Jelena M. Brkljačić, Ana Teofilović, Ivana Božić Antić, Jelica Bjekić Macut, Abdulbaset Zidane Shirif et al. · 2017 · Experimental and Clinical Endocrinology & Diabetes
19. Peripheral blood-derived cytokine gene polymorphisms and metabolic profile in women with polycystic ovary syndrome
    Mirelle O. Sóter, Cláudia Natália Ferreira, Mariana F. Sales, Ana Lúcia Cândido, Fernando Marcos dos Reis, Kátia S. Milagres, Carla R.S.C. Ronda, Iêda de Fátima Oliveira Silva, Marinez Oliveira Sousa, Karina Braga Gomes · 2015 · Cytokine
20. Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol–cyproterone acetate
    Funda Göde, Çiğdem Karagöz, Cemal Posacı, Bahadır Saatli, Didem Uysal, Mustafa Seçil, Bahri Akdeniz · 2010 · Archives of Gynecology and Obstetrics
21. Serum osteoprotegerin concentrations are decreased in women with the polycystic ovary syndrome
    Héctor Francisco Escobar-Morreale, José Ignacio Botella-Carretero, María Ángeles Martínez-García, Manuel Luque‐Ramírez, Francisco Álvarez‐Blasco, José L. San Millán · 2008 · European Journal of Endocrinology
22. Study on the effects of Mogroside V in inhibiting NLRP3-mediated granulosa cell pyroptosis and insulin resistance to improve PCOS
    Wenqin Yang, Yujie Ma, Yafei Wu, Xiaocan Lei, Jing Zhang, Meixiang Li · 2025 · Journal of Ovarian Research
23. Association between metabolic and hormonal profile, proinflammatory cytokines in saliva and gingival health in adolescent females with polycystic ovary syndrome
    Natalia Wendland, Justyna Opydo-Szymaczek, Dorota Formanowicz, Anna Blacha, Grażyna Jarząbek‐Bielecka, Małgorzata Mizgier · 2021 · BMC Oral Health
24. Metabolic profile of women with PCOS in Brazil: a systematic review and meta-analysis
    Poli Mara Spritzer, Ramon Bossardi Ramos, Lucas Bandeira Marchesan, Mônica de Oliveira, Enrico Carmina · 2021 · Diabetology & Metabolic Syndrome
25. Quantitative Changes in White Blood Cells: Correlation with the Hallmarks of Polycystic Ovary Syndrome
    Abdulrahman Hamdan Almaeen, Abdulrahman Abdulwahab Alduraywish, Mudasar Nabi, Naveed Nazir Shah, Shaik Rahiman, Bilal Ahmad Tantry · 2022 · Medicina
26. Type 2 diabetes as an inflammatory disorder
    Naveed A. Sattar, Colin Graham Perry, John R. Petrie · 2003 · The British Journal of Diabetes
27. The Biological Variation of C-Reactive Protein in Polycystic Ovarian Syndrome
    Li Wei Cho, Vijay Jayagopal, Eric S. Kilpatrick, Stephen Lawrence Atkin · 2005 · Clinical Chemistry
28. Predictors of urinary albumin excretion in women with polycystic ovary syndrome
    Antoni J. Dulęba, Ibrahim M. Ahmed · 2009 · Fertility and Sterility
29. Increased monocyte chemoattractant protein-1 levels indicating early vascular damage in lean young PCOS patients
    Cem Somer Atabekoğlu, Murat Sönmezer, Batuhan Özmen, Aslı Yarcı Gürsoy, Filiz Akbıyık, Tolga Taşçı, Ruşen Aytaç · 2010 · Fertility and Sterility
30. Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
    Krystallenia Alexandraki, Eleitho Practice, Athens, Greece, Eleni Kandaraki, Kalliopi‐Anna Poulia, Christina Piperi, Eirini Papadimitriou, Theo Papaioannou · 2021 · touchREVIEWS in Endocrinology
31. Increased pro-inflammatory cytokines in ovary and effect of γ-linolenic acid on adipose tissue inflammation in a polycystic ovary syndrome model
    Yogamaya Divakar Prabhu, Atreyee Borthakur, Subeka A.G, Balachandar Vellingiri, Abilash Valsala Gopalakrishnan · 2021 · Journal of Reproductive Immunology
32. Oxidative stress markers are not valuable markers in lean and early age of polycystic ovary syndrome patients.
    E Cakir, Mustafa Özbek, E Ozkaya, Nujen Çolak, Erman Çakal, Müyesser Saykı, Aşkın Güngüneş, Yüksel Aliyazıcıoğlu, Ahmet Menteşe, Tuncay Delibaşı · 2011 · PubMed
33. Angiotensin converting enzyme gene insertion/deletion polymorphism in patients with polycystic ovary syndrome
    Aysun Karabulut, Sebahat Turgut, Günfer Turgut · 2010 · Gynecological Endocrinology
34. Evaluation of Oxidative Stress and hsCRP in Polycystic Ovarian Syndrome in a Tertiary Care Hospital
    N Sumithra, R. Lakshmi, N. Leela Menon, K. N. Subhakumari, V S Sheejamol · 2014 · Indian Journal of Clinical Biochemistry
35. Increased expression of PGRN protein in follicular fluid and mRNA in granulosa cells in overweight patients with polycystic ovary syndrome
    Danni Zhou, Saijiao Li, Wei Li, Tailang Yin, Wangming Xu, Jun Zhang, Jing Yang · 2017 · European Journal of Obstetrics & Gynecology and Reproductive Biology
36. LncRNA GAS5 is upregulated in polycystic ovary syndrome and regulates cell apoptosis and the expression of IL-6
    Chunxia Wang, Shishi Yue, Yaru Jiang, Yanjia Mao, Zhijing Zhao, Xinwei Liu, Xiaoqian Zhang, Dongxu Pei, Yongwei Li · 2020 · Journal of Ovarian Research
37. Bee venom treatment reduced C-reactive protein and improved follicle quality in a rat model of estradiol valerate-induced polycystic ovarian syndrome
    Latifeh Karimzadeh, Mohammad Nabiuni, Azar Sheikholeslami, Saeed Irian · 2012 · The Journal of venomous animals and toxins including tropical diseases
38. Substituting Poly- and Mono-Unsaturated Fat for Dietary Carbohydrate Reduces Hyperinsulinemia in Women with Polycystic Ovary Syndrome
    Perelman, Dalia, Coghlan, Nicole, Lamendola, Cindy, Carter, Susan, Abbasi, Fahim, McLaughlin, Tracey · 2017 · Gynecological Endocrinology
39. Use of combined oral contraceptives alters metabolic determinants and genetic regulation of C-reactive protein. The Cardiovascular Risk in Young Finns Study
    Haarala, Atte, Eklund, Carita, Pessi, Tanja, Lehtimäki, Terho, Huupponen, Risto, Jula, Antti, Viikari, Jorma, Raitakari, Olli, Hurme, Mikko · 2009 · Scandinavian Journal of Clinical and Laboratory Investigation
40. Saturated fat ingestion stimulates proatherogenic inflammation in polycystic ovary syndrome
    Frank González, Robert V. Considine, Ola A. Abdelhadi, Jiaping Xue, Anthony J. Acton · 2021 · American Journal of Physiology-Endocrinology and Metabolism
41. Blood pressure in postmenopausal women with a history of polycystic ovary syndrome
    Katarzyna Doroszewska, Tomasz Milewicz, Sandra Mrozińska, Jarosław Janeczko, Radosław Rokicki, Marek Janeczko, Damian Warzecha, Piotr Marianowski · 2019 · Menopause Review/Przegląd Menopauzalny
42. Chronic inflammation in polycystic ovary syndrome: A case–control study using multiple markers
    Soumik Goswami, Subhadip Choudhuri, Basudev Bhattacharya, Rana Bhattacharjee, Ajitesh Roy, Satinath Mukhopadhyay, Sujoy Kumar Ghosh, Subhankar Chowdhury · 2021 · International Journal of Reproductive BioMedicine (IJRM)
43. Adipose tissue inflammation and metabolic dysfunction: a clinical perspective
    Charmaine S. Tam, Leanne Maree Redman · 2013 · Hormone Molecular Biology and Clinical Investigation
44. Evidence for statin therapy in polycystic ovary syndrome
    Thozhukat Sathyapalan, Stephen Lawrence Atkin · 2010 · Therapeutic Advances in Endocrinology and Metabolism
45. Thiazolidinediones for the Therapeutic Management of Polycystic Ovary Syndrome
    Karen E Elkind-Hirsch · 2006 · Treatments in Endocrinology
46. Efficacy of Myo-inositol on anthropometric, metabolic, and endocrine outcomes in PCOS patients: a meta-analysis of randomized controlled trial
    Jethaliya, Hardik, Gajjar, Nirva, Patel, Vrushank, Deshpande, Shrikalp, Patel, Roshni · 2022 · Reproductive Sciences
47. Chronic anovulation and the polycystic ovary syndrome
    NATHAN G. KASE · 2013 · Cambridge University Press eBooks
48. The Relationship Between Polycystic Ovarian Syndrome, Periodontal Disease, and Osteoporosis
    Hannah E. Young, Wendy Elizabeth Ward · 2020 · Reproductive Sciences
49. Possible Role of Metformin as an Immune Modulator in the Tumor Microenvironment of Ovarian Cancer
    Faye K. Tsogas, Daniel Majerczyk, Peter C. Hart · 2021 · International Journal of Molecular Sciences
50. Interplay between Oxidative Stress and Chronic Inflammation in PCOS: The Role of Genetic Variability in PCOS Risk and Treatment Responses
    Rok Herman, Mojca Jensterle, Andrej Janež, Vita Dolžan · 2019 · IntechOpen eBooks
51. Is Hepcidin a New Cardiovascular Risk Marker in Polycystic Ovary Syndrome?
    Elif Gözdemir, İkbal Kaygusuz, Hasan Candaş Kafalı · 2013 · Gynecologic and Obstetric Investigation
52. Relationship between interleukin-6 levels and ambulatory blood pressure in women with polycystic ovary syndrome
    Cemil Kaya, Recai Pabuçcu, Cemile Koca, Ali Kemal Oğuz, Aycan Fahri Erkan, Ayhan Korkmaz, Deniz Erbaş · 2009 · Fertility and Sterility
53. Hyperandrogenic environment regulates the function of ovarian granulosa cells by modulating macrophage polarization in PCOS
    Xi Chen, Ling Hong, Lianghui Diao, Tailang Yin, Su Liu · 2024 · American Journal of Reproductive Immunology
54. Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease
    Mingqin Shi, Xinyao Li, Liwei Xing, Zhenmin Li, Sitong Zhou, Zihui Wang, Xuelian Zou, Yuqing She, Rong Zhao, Dongdong Qin · 2024 · Pharmaceutics
55. A network pharmacology study of mechanism and efficacy of Jiawei Huanglian-Wendan decoction in polycystic ovary syndrome with insulin resistance
    Na Shi, Yuhe Zhou, Hongbo Ma · 2022 · Medicine
56. Oncostatin M Is Related to Polycystic Ovary Syndrome-Case Control Study
    Figen Efe Çamili, Merve Akış, Ertan Adalı, Adnan Adil Hişmioğulları, Mine İslimye Taşkın, Gürhan Güney, Selim Afşar · 2024 · Biomedicines
57. Diagnostic and prognostic biomarkers in Polycystic Ovary Syndrome
    Ishanka Singh, Kareena Moar, Pawan Kumar Maurya · 2025 · Clinica Chimica Acta
58. Reimbursement of metformin for polycystic ovary syndrome
    Andrzej Milewicz · 2013 · Endokrynologia Polska
59. Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women
    Hui Yuan Gao, J. Meng, Hui Xing, Shuke Nie, Menglei Xu, S. Zhang, Y. Jin, Taoping Sun, Hongbiao Huang, H. Zhang et al. · 2014 · Human Reproduction
60. Evaluation of hs-CRP and visseral adiposity index in patients with policystic ovary syndrome by clinical and laboratory findings
    Burak Ün, Kenan Dolapçıoğlu, Ayşe Güler Okyay, Hatice Nihal Şahin, A. Beyazıt · 2016 · European Journal of Obstetrics & Gynecology and Reproductive Biology
61. Polymorphisms of Cytokine Genes and Polycystic Ovary Syndrome: A Review
    Josiane Bazzo de Alencar, Hugo Vicentin Alves, Laise Nayana Sala Elpídio, Jeane Eliete Laguila Visentainer, Ana Maria Sell · 2016 · Metabolic Syndrome and Related Disorders
62. Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome
    Sedighe Moradi, Mina Mollabashi, Scott Reza Jafarian Kerman · 2010 · Gynecological Endocrinology
63. Increased serum neopterin levels in women with polycystic ovary syndrome.
    Burcu Barutçuoğlu, A Erkin Bozdemir, Didem Dereli, Zuhal Parıldar, Mert Mutaf, Dilek Ozmen, Oya Bayındır · 2006 · PubMed
64. The Association Between Increment of Interleukin-1 and Interleukin-6 in Women with Polycystic Ovary Syndrome and Body Mass Index
    Sahar Mazloomi, Zeinab Barartabar, Shamim Pilehvari · 2023 · Journal of Reproduction & Infertility
65. Association between Interleukin-32 and Interleukin-17A Single Nucleotide Polymorphisms and Serum Levels with Polycystic Ovary Syndrome
    Fatemeh Hesampour, Bahia Namavar Jahromi, Foroozan Tahmasebi, Behrouz Gharesi‐Fard · 2019 · Iranian Journal of Allergy Asthma and Immunology
66. Identification of the key pathways and genes related to polycystic ovary syndrome using bioinformatics analysis
    X. Bi, Z. Zhai, Shaohua Wang · 2019 · General Physiology and Biophysics
67. Expression of nuclear receptors of gingiva in polycystic ovarian syndrome: a preliminary case study
    Ketkee P. Asnani, Dr Mohan Hingorani, Supriya Mohit Kheur, Vijay L. Deshmukh, Georgios E. Romanos · 2014 · Australian Dental Journal
68. Determinants of Interleukin-6 and C-Reactive Protein Vary in Polycystic Ovary Syndrome, as Do Effects of Short- and Long-Term Metformin Therapy
    Tasoula Tsilchorozidou, Vidya Mohamed‐Ali, Gerard S. Conway · 2009 · Hormone Research in Paediatrics
69. Association of Mean Platelet Volume With Androgens and Insulin Resistance in Nonobese Patients With Polycystic Ovary Syndrome
    Bercem Aycicek Dogan, Ayşe Arduç, Mazhar Müslüm Tuna, Ersen Karakılıç, İffet Dağdelen Duran, Yasemin Tütüncü, Dilek Sensoz Berker, Serdar Güler · 2014 · Intern J Endocrinol Metab
70. Conicity index as a contributor marker of inflammation in haemodialysis patients.
    Mar Ruperto, Guillermina Barril, Francisco José Sánchez-Muniz · 2013 · PubMed
71. C-Reactive Protein in Obese PCOS Women and the Effect of Metformin Therapy
    Zelija Velija-Ašimi · 2007 · Biomolecules and Biomedicine
72. Insulin Is an Anti-inflammatory and Anti-atherosclerotic Hormone
    Paresh Dandona, Ahmad Aljada, Amy O’Donnell, Sandeep Dhindsa, Rajesh Garg · 2004 · Metabolic Syndrome and Related Disorders
73. Is the polycystic ovary syndrome the causative of the increase in inflammatory markers and metabolic risk?
    Estela Beatriz Rey-Roldán, Maria Belén Perez Lana, Liliana Galluzzo, Georgina Blanco, Claudia Onetto, Vanesa Straminsky, Manuel Nolting · 2012 · Gynecological Endocrinology
74. The role of chronic inflammation and Leu55Met PON1 polymorphism in the pathogenesis of polycystic ovary syndrome
    Agnieszka Lenarcik, Bożena Bidzińska−Speichert, Urszula Tworowska-Bardzińska · 2010 · Gynecological Endocrinology
75. HEART RATE VARIABILITY AND LIPID PROFILE IN NON OBESE YOUNG INDIAN WOMEN WITH POLYCYSTIC OVARY SYNDROME
    Malathi Balamurugan, Malathi Balamurugan, Gomathi Ramanathan · 2015 · Journal of Evolution of Medical and Dental Sciences
76. Associated Effects of Endocrine Disrupting Chemicals (EDCs) on Neuroendocrine Axes and Neurotransmitter Profile in Polycystic Ovarian Syndrome Condition
    Poornima Ananthasubramanian, S. Vijay Ananth, Sanjana Kumaraguru, Barathi Seetharaman, Winkins Santosh, Ramasamy Vasantharekha · 2021 · Proceedings of the Zoological Society
77. Association between polycystic ovary syndrome and the risk of malignant gynecologic cancers (ovarian, endometrial, and cervical): A population-based study from the U.S.A. National Inpatient Sample 2016–2019
    Ahmed Abu‐Zaid, Saeed Baradwan, Mohammad Alyafi, Maha Al Baalharith, Saud Owaimer Alsehaimi, Mohannad Alsabban, Saud Abdullah Alsharif, Saad M. S. Alqarni, Hedaya Albelwi, Mohammed Ziad Jamjoom et al. · 2024 · European Journal of Obstetrics & Gynecology and Reproductive Biology
78. Fat Distribution and its Correlation with Insulin Resistance, Androgen Markers, and Proinflammatory Cytokines in Polycystic Ovary Syndrome
    Rebeca Bandeira de Melo Cavalcante, Lenora Maria Camarate Silveira Martins Leão, Ana Beatriz Winter Tavares, Karynne Grutter Lopes, Luiz Guilherme Kraemer‐Aguiar · 2024 · Hormone and Metabolic Research
79. Impact of interlukin-6 on central obesity measures in women with polycystic ovarian syndrome
    Eman Mokbel Alissa, Samiah A. Algarni, Azza J. Khaffji, Nisma M. Al Mansouri · 2020 · Journal of Obstetrics and Gynaecology
80. Lipid-induced mononuclear cell cytokine secretion in the development of metabolic aberration and androgen excess in polycystic ovary syndrome
    Frank González, Robert V. Considine, Ola A. Abdelhadi, Anthony J. Acton · 2020 · Human Reproduction
81. Pentraxin 3 Levels in Young Women with and without Polycystic Ovary Syndrome (PCOS) in relation to the Nutritional Status and Systemic Inflammation
    Katarzyna Wyskida, Grzegorz Franik, Piotr Stanisław Choręza, Natalia Pohl, Leszek Markuszewski, Aleksander Jerzy Owczarek, Paweł Madej, Jerzy Tadeusz Chudek, Magdalena Olszanecka‐Glinianowicz · 2020 · International Journal of Endocrinology
82. Can polyunsaturated fatty acids regulate Polycystic Ovary Syndrome via TGF-β signalling?
    Yogamaya Divakar Prabhu, Abilash Valsala Gopalakrishnan · 2021 · Life Sciences
83. Ibuprofen inhibits key genes involved in androgen production in theca–interstitial cells
    Chelsea Webb Fox, Lingzhi Zhang, Benjamin C. Moeller, V. Gabriel Garzo, R. Jeffrey Chang, Antoni J. Dulęba · 2021 · F&S Science
84. Proteomics and genomics: A hypothesis‐free approach to the study of the role of visceral adiposity in the pathogenesis of the polycystic ovary syndrome
    Héctor Francisco Escobar-Morreale, María Rosa Insenser, Marta Cortón, José L. San Millán, Belén Peral · 2008 · PROTEOMICS - CLINICAL APPLICATIONS
85. Inflammatory Response Patterns in ICSI Patients: A Comparative Study Between Chronic Anovulating and Normally Ovulating Women
    Rívia Mara Lamaita, Anaglória Pontes, Andrezza Vilaça Belo, Joäo Pedro Junqueira Caetano, Sílvia Passos Andrade, Eduardo Batista Cândido, Paulo Traiman, Márcia Mendonça Carneiro, Agnaldo Lopes da Silva Filho · 2012 · Reproductive Sciences
86. Increased serum C-reactive protein levels in normal weight women with polycystic ovary syndrome.
    Anastasios Makedos, Dimitrios G. Goulis, Malamatenia Arvanitidou, Gesthimani Mintziori, Alexis Papanikolaou, Areti Makedou, Dimitrios Panidis · 2011 · PubMed Central
87. Anti-inflammatory Effect of Silymarin on Ovarian Immunohistochemical Localization of TNF- Associated with Systemic Inflammation in Polycystic Ovarian Syndrome
    Parvin Kayedpoor, Shima Mohamadi, Latifeh Karimzadeh, Mohammad Nabiuni · 2017 · International Journal of Morphology
88. Increased fibulin-1 plasma levels in polycystic ovary syndrome (PCOS) patients: possible contribution to the link between PCOS and cardiovascular risk
    Elisa Scarinci, Anna Tropea, Giulio Russo, Giovanna Notaristefano, Calogero Messana, Ornella Alesiani, S. M. Fabozzi, Antonio Lanzone, Rosanna Apa · 2018 · Journal of Endocrinological Investigation
89. Effect of Chromium Supplementation on Element Distribution in a Mouse Model of Polycystic Ovary Syndrome
    Tsung-Sheng Chen, Yi‐Ting Chen, Chia-Hsin Liu, Chi‐Ching Sun, Frank Chiahung Mao · 2015 · Biological Trace Element Research
90. Serum High-Sensitivity C-Reactive Protein and Homocysteine Changes During Hormonal Therapy in Women With Polycystic Ovary Syndrome: A Prospective, Matched Study
    Anastasios Makedos, Dimitrios G. Goulis, Alexis Papanikolaou, Dimitrios Panidis · 2010 · Angiology
91. Review: PCOS, insulin resistance and long-term risks for diabetes and vascular disease
    Naveed A. Sattar · 2009 · The British Journal of Diabetes
92. Insulin Resistance in Polycystic Ovarian Disease
    Vishal Bhatia · 2005 · Southern Medical Journal
93. Serum myeloperoxidase and adenosine deaminase activities in polycystic ovary syndrome
    Zehra Kurdoğlu, Halil Özkol, Mertihan Kurdoğlu · 2011 · Gynecological Endocrinology
94. Neopterin: a promising marker for the inflammation in polycystic ovary syndrome
    İbrahim Alanbay, Cihangir Mutlu Ercan, Hakan Çoksüer, Mehmet Sakıncı, Kazım Emre Karaşahin, Özlem Öztürk, Halıl Yaman · 2012 · Gynecological Endocrinology
95. Modificações do estilo de vida na síndrome dos ovários policísticos: papel do exercício físico e importância da abordagem multidisciplinar
    George Dantas Azevedo, Eduardo Caldas Costa, Maria Thereza Albuquerque Barbosa Cabral Micussi, Joceline Cássia Ferezini de Sá · 2008 · Revista Brasileira Ginecologia e Obstetrícia
96. Metformin and polycystic ovary syndrome
    Tessa G Lebinger · 2007 · Current Opinion in Endocrinology Diabetes and Obesity
97. Does endocan level increase in women with polycystic ovary syndrome? A case — control study
    İlhan Bahri Delibaş, Ömer Erkan Yapça, Esra Laloğlu · 2018 · Ginekologia Polska
98. The connection of alpha‐1 acid glycoprotein inflammatory marker with anthropometric, hormonal, and metabolic characteristic of women with polycystic ovary syndrome
    Sebastião Freitas de Medeiros, Matheus Antônio Souto de Medeiros, Bruna Barcelo Barbosa, Ana Karine Lin Winck Yamamoto, Márcia Marly Winck Yamamoto · 2021 · Journal of obstetrics and gynaecology research
99. Heart type fatty acid binding protein response and subsequent development of atherosclerosis in insulin resistant polycystic ovary syndrome patients
    Evrim Çakır, Mustafa Özbek, Mustafa Şahi̇n, Erman Çakal, Aşkın Güngüneş, Zeynep Giniş, Taner Demirci, Tuncay Delibaşı · 2012 · Journal of Ovarian Research
100. Beneficial effect of metformin on pregnancy outcome in women with polycystic ovary syndrome is not associated with major changes in C-reactive protein levels or indices of coagulation
     Eszter Vanky, Kjell Åsmund Salvesen, Henrik Hjorth‐Hansen, Kristian S. Bjerve, Sven Magnus Carlsen · 2006 · Fertility and Sterility